Quick Answer
Cocrystal Pharma, Inc. reported Gross Profit of $7.22 million for fiscal year 2012.
Cocrystal Pharma, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2012 | $7.22M | +168.9% |
| 2011 | $2.69M | -60.7% |
| 2010 | $6.83M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2013 | $1.11M | -41.8% | +101.2% |
| June 30, 2013 | $551.7K | -72.8% | -6.8% |
| March 31, 2013 | $592.1K | -59.0% | -68.9% |
| September 30, 2012 | $1.91M | -8.6% | -6.1% |
| June 30, 2012 | $2.03M | — | +40.5% |
| March 31, 2012 | $1.45M | -14.5% | -30.7% |
| September 30, 2011 | $2.09M | -1.4% | +23.3% |
| March 31, 2011 | $1.69M | — | -20.1% |
- Cocrystal Pharma, Inc. showed an increase of +168.9% in Gross Profit compared to the prior fiscal year.
- Over the 2010–2012 period, Cocrystal Pharma, Inc.’s gross profit has grown by 5.8% (from $6.83 million to $7.22 million).
- The most recent figure is from Cocrystal Pharma, Inc.’s fiscal year 2012 report (Form 10-K), filed with the SEC on April 1, 2013.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: